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Abstract
ATP-dependent chromatin-remodeling complexes contribute to the proper temporal and spatial
patterns of gene expression in mammalian embryos and therefore play important roles in a number
of developmental processes. SWI/SNF-like chromatin-remodeling complexes use one of two
different ATPases as their catalytic subunit: brahma (BRM, also known as SMARCA2) and brahma-
related gene 1 (BRG1, also known as SMARCA4). We have conditionally deleted a floxed Brg1
allele with a Tie2-Cre transgene, which is expressed in developing hematopoietic and endothelial
cells. Brg1fl/fl:Tie2-Cre+ embryos die at midgestation from anemia, as mutant primitive erythrocytes
fail to transcribe embryonic α-and β-globins, and subsequently undergo apoptosis. Additionally,
vascular remodeling of the extraembryonic yolk sac is abnormal in Brg1fl/fl:Tie2-Cre+ embryos.
Importantly, Brm deficiency does not exacerbate the erythropoietic or vascular abnormalities found
in Brg1fl/fl:Tie2-Cre+ embryos, implying that Brg1-containing SWI/SNF-like complexes, rather than
Brm-containing complexes, play a crucial role in primitive erythropoiesis and in early vascular
development.
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INTRODUCTION
Developmental processes require changes in gene expression to achieve cellular
differentiation. Eukaryotes use chromatin-modifying factors to aid in the regulation of gene
expression because large nuclear factors necessary for transcription cannot access DNA when
it is tightly bound to histones in nucleosomes. Two main classes of chromatin-modifying
factors achieve changes in chromatin structure and organization at individual genes. One class
covalently modifies histone proteins to achieve a heritable epigenetic mark instructing further
genetic regulation. The second class uses energy derived from ATP hydrolysis to alter the
conformation or position of nucleosomes, thereby transiently making gene promoters
accessible or inaccessible to large nuclear factors. Both classes of chromatin-modifying factors
are necessary to achieve proper temporal and spatial patterns of gene expression in the embryo,
and therefore play important roles in a number of developmental processes (de la Serna et al.,
2006; Margueron et al., 2005).
The mammalian SWI/SNF-related chromatin-remodeling complexes comprise one major
family of ATP-dependent chromatin-modifying factors. These large, multi-protein complexes
use one of two different ATPases as their catalytic subunit: brahma (BRM, also known as
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SMARCA2) and brahma-related gene 1 (BRG1, also known as SMARCA4). The significance
of SWI/SNF-related complexes in mammalian development is particularly well demonstrated
by the phenotypes associated with mice carrying mutations in Brg1. Brg1-/- embryos die at the
peri-implantation stage of development, and conditional alleles have been used to demonstrate
the role of Brg1 in T-cell development, limb morphogenesis, skin development, gliogenesis
and zygotic genome activation (Bultman et al., 2000; Bultman et al., 2006; Gebuhr et al.,
2003; Indra et al., 2005; Matsumoto et al., 2006). By contrast, Brm-/- mice develop normally,
although adult mutants are 15% heavier than their control littermates, possibly because of
increased cellular proliferation (Reyes et al., 1998). As BRG1 is significantly upregulated in
Brm-/- mice, it has been hypothesized that BRG1 can functionally compensate for the loss of
BRM during development (Reyes et al., 1998).
We previously isolated and characterized an N-ethyl-N-nitrosourea (ENU)-induced point
mutation in Brg1 (Brg1ENU1) that changes a single amino-acid residue (E1083G) in a highly
conserved region of the catalytic ATPase domain (Bultman et al., 2005). The mutant protein
is stable, assembles into SWI/SNF-related complexes, and exhibits normal ATPase activity,
but has diminished nucleosome-remodeling capability. Brg1null/Brg1ENU1 embryos fail to
transcribe adult β-globin genes, thereby indicating that BRG1 plays an important role in
chromatin remodeling of the β-globin locus during definitive erythropoiesis. However, because
hypomorphic Brg1null/Brg1ENU1 embryos express embryonic β-globin genes and undergo
normal primitive erythropoiesis, it has been unclear whether BRG1 and SWI/SNF-related
complexes are involved in this earlier hematopoietic process. Using a conditional null allele,
we now report that BRG1, but not BRM, is indeed recruited to the β-globin locus control region
in primitive erythrocytes, and is required for the transcription of embryonic β-globin genes and
for erythroblast survival. We also demonstrate for the first time that BRG1 is required for
embryonic α-globin expression, although expression of adult α-globins does not depend upon
BRG1-induced remodeling in primitive erythrocytes. Finally, BRG1 appears to play an




The Brg1-floxed mice (Gebuhr et al., 2003), the Brm-/- mice (Reyes et al., 1998), the Tie2-
Cre transgenic mice (Koni et al., 2001) and the ROSA26R mice (Soriano, 1999) have been
described. All mice were maintained on a mixed genetic background at the University of North
Carolina, Chapel Hill Animal Facility. Brg1-floxed mice were genotyped by Southern blot
analysis using a 449 bp probe against the 3′ portion of intron 14 and genomic DNA digested
with BamHI. The PCR primers used to generate the Southern probe were as follows: forward,
5′-TGGCATCTCATTTGTGTGGT-3′; and reverse, 5′-ACAGCCACTGGTTAGGGATG-3′.
The Southern blot yields a 7.7 kb floxed allele, a 6.0 kb wild-type allele and a 5.5 kb excised
allele. Brg1-floxed embryos were genotyped by PCR using the following primers: forward, 5′-
GTCATACTTATGTCATAGCC-3′; and reverse, 5′-GCCTTGTCTCAAACTGATAAG-3′.
These primers flank the 3′ LoxP site, and yield a 387 bp floxed allele and a 230 bp wild-type
allele. The PCR was performed at an annealing temperature of 51°C. Brm-/- mice and embryos
were genotyped by PCR using the following primers for the 197 bp wild-type allele: forward,
5′-ATATCTGGAGGAGGCCCAAC-3′; and reverse, 5′-
TGCAGAGTTTCAGGGAGAGG-3′. The 600 bp targeted allele was amplified using the same
forward primer and the following reverse primer: 5′-CATCGCCTTCTATCGCCTTC-3′. The
PCR was performed at an annealing temperature of 55°C. Tie2-Cre transgenic mice and
embryos were genotyped using a gene-specific forward primer (5′-
GGGAAGTCGCAAAGTTGTGAGTT-3′) and a Cre-specific reverse primer (5′
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GTGAAACAGCATTGCTGTCACTT-3′) that amplifies a 400 bp product. Control primers
amplifying a 324 bp product from the IL2 gene were used as a template control: forward, 5′-
CTAGGCCACAGAATTGAAAGATCT-3′; and reverse, 5′-
GTAGGTGGAAATTCTAGCATCATCC-3′. The PCR was performed at an annealing
temperature of 51°C. ROSA26R mice were genotyped as described (Soriano, 1999). All
histological sections were scraped from paraffin or OCT (Tissue-Tek) into DEXPAT Reagent
(TaKaRa) before genotyping.
Histology
Embryos and yolk sacs were dissected from maternal tissue, immersion-fixed in 4%
paraformaldehyde overnight, dehydrated, embedded in paraffin, sectioned (10 μm), and stained
with hematoxylin and eosin. For cryosections, embryos were dissected, fixed, and passed
through 10% sucrose (10 minutes), 15% sucrose (10 minutes), 20% sucrose (1 hour) and 20%
sucrose/OCT (overnight), and then embedded in OCT on dry ice before sectioning (10 μm)
and mounting on Superfrost/Plus microscope slides (Fisher). Electron microscopy was
performed as described (Schwarz et al., 2002) on embryonic day 10.5 (E10.5) yolk sacs from
two mutant and two control littermate embryos with visible heart beats.
Staining
Whole-mount immunostaining for platelet/endothelial cell adhesion molecule 1 (PECAM1)
was performed as described using a rat anti-mouse PECAM1 monoclonal antibody (BD
PharMingen) (Schlaeger et al., 1995). Whole-mount β-galactosidase staining was performed
as described (Schlaeger et al., 1995), and stained embryos were subsequently cryosectioned
and counterstained with Nuclear Fast Red. Transferase-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL) staining was performed on paraffin-embedded tissues
using the In Situ Cell Death Detection Kit, Fluorescein (Roche), according to the
manufacturer’s instructions. Benzidine staining was performed on cryosectioned embryos and
yolk sacs. After a brief submersion in PBS, slides were incubated in methanol (15 seconds),
1% benzidine (Sigma-Aldrich) in methanol (5 minutes), 2.5% hydrogen peroxide in 70%
ethanol (2.5 minutes), and washed in water (2.5 minutes).
In situ hybridization
Gene-specific antisense probes to the murine εy, βH1, ζ and α1/2 globins have been described
(Kingsley et al., 2006). A 382 bp antisense probe for murine Band3 was amplified from E8.5
yolk sac cDNA using the following primers: forward, 5′-
AGAGACCTAACCATCCCTGTGA-3′; and reverse, 5′-
TCTGATCCTCGTAGATGAAGCA-3′. A 425 bp antisense probe for murine Alas2 was
amplified from E8.5 yolk sac cDNA using the following primers: forward, 5′-
CCATGCTGTAGGACTGTATGGA-3′; and reverse, 5′-
CATAGATGCTGTGCTTGGAGAG-3′. In vitro transcription was performed to generate
digoxigenin-labeled RNA probes. Cryosectioned embryos were subjected to a 10-minute
proteinase K (2.5 μg/ml) pre-treatment before in situ hybridization. Prehybridization and
hybridization incubations were carried out at 60°C in a mixture of 50% formamide, 5×SSC,
2% blocking reagent (Roche), 0.1% Triton-X100, 0.5% CHAPS, 50 μg/ml yeast tRNA, 5 mM
EDTA and 100 μg/ml heparin. After overnight hybridization, slides were washed and incubated
with anti-digoxigenin-AP Fab fragments (Roche) overnight at 4°C. After further washing,
slides were incubated with NBT/BCIP at room temperature for several hours, or at 4°C for up
to three days.
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To obtain primitive erythrocytes, approximately 40 wild-type E9.5-E10.5 embryos were
separated from their placentae by severing the umbilical vessels. The embryos with their
attached yolk sacs were immediately placed in minimal essential media containing 2% fetal
bovine serum (JRH Biosciences) and were rocked on a Nutator mixer for approximately 30
minutes at room temperature while allowing the hearts to pump the majority of circulating
blood out of the embryos and yolk sacs. Embryos and yolk sacs were removed from the media,
and the remaining blood cells were counted on a hemocytometer. Typically 20×106 to
50×106 blood cells were collected. The fresh cells were used in ChIP assays as previously
described (Bultman et al., 2005), with some modifications: 7×106 cells were used for each
ChIP or mock reaction; 0.6% formaldehyde was used to cross-link the protein-protein and
protein-DNA interactions; and chromatin was sonicated with eleven 10-second pulses at 10%
maximum power on a Branson Digital Sonifier. The anti-BRG1 antibody J1 (a gift from G.
Crabtree and W. Wang, Stanford University) and the anti-acetyl-histone 3 antibody (Santa
Cruz, 06-599) were used for immunoprecipitations. The β-globin locus control region DNAseI
hypersensitive site 3 (HS3) primers that were used for amplification of the ChIP products and
controls were as follows: forward, 5′-AGGCCTCCTAGGGACTGAGA-3′; and reverse, 5′-
AGACTCCACCCTGAGCTGAA-3′. The 158 bp product was amplified at an annealing
temperature of 55°C for 35 cycles. The ζ amplicon spans 271bp of the promoter starting 535
bp upstream of the start site, and the PCR primers were as follows: forward, 5′-
TATGGAGGGCTAGCTGGAGA-3′; and reverse, 5′-GGCCTTAGTCCCACACAGAA-3′.
The product was amplified at an annealing temperature of 55°C for 34 cycles. The α1/2 primers
used for ChIP amplification were as follows: forward, 5′-
GGGAGGAGACAGTGGACAAA-3′; and reverse, 5′-AGTGATGGCAGTTTGGGAAG-3′.
The amplicon spans 257 bp of the promoter starting 515 bp upstream of the α1 start site, and
was amplified at an annealing temperature of 55°C for 30 cycles. Cycle numbers were
determined for each amplicon based on the maximum amount of amplification that could be
achieved before background bands appeared in the mock (no antibody) control lane.
Image acquisition
Brightfield histological images were obtained with a Leica DM IRB microscope (Leica
Microsystems) using 10× (NA 0.25) and 20× (NA 0.4) objectives with a 1.5× magnification
changer and a SPOT RT-Slider digital camera (Diagnostic Instruments). Images were acquired
with SPOT RT Software version 4.5 (Diagnostic Instruments) and were globally optimized for
brightness/contrast, if necessary, using Photoshop software (Adobe). Whole yolk sacs were
imaged on a Leica MZ FLIII microscope (Leica Microsystems) using the camera and
acquisition software described above. Fluorescent TUNEL images were obtained with a Leica
DM LB Microscope (Leica Microsystems) using a 40× (NA 0.7) objective and a Retiga-2000R
digital camera (QImaging). Black and white images were acquired with QCapture Software
version 3.0 (QImaging), and were pseudocolored and merged with SPOT RT Software.
RESULTS
Brg1fl/fl:Tie2-Cre+/0 embryos die during development
We initially analyzed mice carrying a conditionally floxed allele of Brg1 in combination with
a Tie2-Cre recombinase transgene, which is expressed in developing hematopoietic and
endothelial cells (Koni et al., 2001). We recovered no live Brg1fl/fl:Tie2-Cre+/0 offspring from
matings between Brg1fl/fl and Brg1fl/+:Tie2-Cre+/0 mice (Table 1), indicating that expression
of Brg1 on Tie2+ cells is critical for embryonic development. These data also indicate that
BRM does not compensate for loss of BRG1 on Tie2+ cells, despite the observation that BRG1
and BRM can play partially redundant roles in vitro (Chiba et al., 1994; Phelan et al., 1999;
Strobeck et al., 2002).
Griffin et al. Page 4













Further evidence that BRM is not functionally redundant with BRG1 in developing
endothelium and hematopoietic cells comes from our observation that ablation of Brm does
not result in any detectable phenotype on a Brg1fl/+:Tie2-Cre+/0 background (Table 2).
Lethality of Brm-/-;Brg1fl/+:Tie2-Cre+/0 embryos might have been predicted if a threshold
level of Brg1 and Brm were required in Tie2+ cells during development. However
Brm-/-;Brg1fl/+:Tie2-Cre+/0 progeny were recovered from crosses between Brm-/-;Brg1fl/fl and
Brm-/-;Brg1fl/+:Tie2-Cre+/0 mice in expected numbers. Together, our genetic data clearly
illustrate the importance of Brg1 over Brm in hematopoietic and/or vascular development.
Brg1fl/fl:Tie2-Cre+/0 blood cells undergo apoptosis
In order to determine the time of death of Brg1fl/fl:Tie2-Cre+/0 embryos, we performed
dissections on E8.5-E12.5 embryos. We chose midgestation for our initial analysis as many
mutants with hematopoietic or vascular defects die at this developmental stage (Coultas et al.,
2005; Orkin and Zon, 1997). We determined that Brg1fl/fl:Tie2-Cre+/0 embryos die at E10.5-
E11.0, based on the absence of a visible heartbeat and the onset of necrosis. By E9.5, mutant
embryos are visibly paler than their control littermates, and mutant yolk sacs lack the large,
blood-filled vitelline vessels that are readily visible in control yolk sacs. Importantly, no
exacerbation of the timing or severity of this gross mutant phenotype is detected on a Brm-/-
background (11 Brm-/-;Brg1fl/fl:Tie2-Cre+/0 embryos were assessed at E9.5-E10.5), further
demonstrating the importance of Brg1 over Brm in hematopoietic and/or vascular development.
The extreme pallor of mutant embryos at E9.5 cannot be explained by hemorrhage. Upon gross
dissection, no embryonic blood is visibly pooled in the extravascular exocoelomic, amniotic
or pericardial cavities of mutant embryos. Likewise, histological analysis of control and mutant
embryos from 19 litters (E8.5-E10.5), embedded intact within the maternal uterus so as not to
disrupt any sites of pooled embryonic blood, failed to reveal any sign of hemorrhage.
The extraembryonic yolk sac is the initial site of hematopoiesis and produces large, nucleated
blood cells that begin to circulate between the yolk sac and embryo at E8.25 (McGrath et al.,
2003). Such blood cells are abundant in histological sections of E8.5 Brg1fl/fl:Tie2-Cre+/0 yolk
sacs, demonstrating that hematopoiesis is unimpaired (Fig. 1B). However, by light and electron
microscopy, a dramatic scarcity of blood cells is found in mutant embryos and yolk sacs at
E9.5 and E10.5 (Fig. 1D). Furthermore, many of those blood cells that remain are fragmented
and show abnormal membrane or nuclear morphology (Fig. 1F). In order to determine whether
embryonic blood cells undergo apoptosis between E8.5 and E9.5, we performed TUNEL
staining on sections of E9.5 mutant and control littermate embryos and yolk sacs. Blood cells
from mutant embryos show more evidence of TUNEL staining than do those from control
embryos (13.6±0.75% versus 0.4±0.2%, mean±s.e.m.), indicating that blood from
Brg1fl/fl:Tie2-Cre+/0 embryos is subject to aberrant apoptosis (Fig. 2).
To determine whether the blood cell death detected in mutant embryos is cell autonomous, we
crossed Brg1fl/fl:Tie2-Cre+/0 embryos onto the ROSA26R mouse line (Soriano, 1999).
ROSA26R mice express β-galactosidase upon Cre-mediated deletion of a ‘STOP’ signal;
therefore, cells that express Tie2-Cre turn blue upon X-gal staining in the presence of this
reporter line. At E8.5, both control and mutant embryos display blue endothelium and
comparable amounts of blue blood cells in their yolk sac vasculature (Fig. 3A,B,E). These data
indicate that the majority of embryonic blood cells express Tie2-Cre at E8.5 and that Brg1 is
not required for production of these cells. At E9.5, both control and mutant embryos continue
to display blue endothelium, but whereas control embryos reveal a preponderance of circulating
blue blood cells (86±3.9%), mutants (which contain fewer blood cells overall) display a
minority of blue blood cells (33.5±11.5%; Fig. 3C-E). Additionally, many of the blue blood
cells in mutants are fragmented or display abnormal morphology (Fig. 3D, inset), whereas the
non-blue blood cells retain normal morphology. This indicates that blood cells undergoing
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Brg1 excision are selectively destroyed in a cell-autonomous fashion while wild-type blood
cells are spared from destruction. Therefore, we conclude that Brg1fl/fl:Tie2-Cre+/0 blood cells
are initially formed but subsequently undergo apoptosis between E8.5 and E10.5.
Brg1fl/fl:Tie2-Cre+/0 blood cells have defective embryonic globin transcription
The majority of circulating blood cells at E9.5 are large, nucleated erythroblasts, which are
generated in yolk sac blood islands between E7.25-E9.0 (Palis et al., 1999; Wong et al.,
1986). Once formed, these ‘primitive’ erythroblasts continue to divide for several days before
entering the blood stream, undergoing maturation, and eventually enucleating (Kingsley et al.,
2004). ‘Definitive’ erythroblasts, which originate in the yolk sac, placenta and aorta/gonad/
mesonephros region, colonize the fetal liver where they expand and differentiate before
entering the blood stream as mature, enucleated erythrocytes at E11.5-E12.5 (reviewed by
McGrath and Palis, 2005; Mikkola et al., 2005). Definitive erythrocytes are the predominant
cell type in the embryonic circulation after E12.5.
As they mature, both primitive and definitive erythroblasts accumulate hemoglobin, the
oxygen-carrying component of red blood cells. In order to assess the production of hemoglobin
in Brg1fl/fl:Tie2-Cre+/0 embryonic blood cells, we stained histological sections of control and
mutant E9.5 embryos with benzidine (see Fig. S1 in the supplementary material). Although
blood cells in control embryos exhibit strong staining, many blood cells in mutant embryos
show little or no benzidine staining. These data indicate that hemoglobin production and/or
accumulation is defective in Brg1fl/fl:Tie2-Cre+/0 primitive erythrocytes.
Globin tetramers encoded by the α-and β-globin gene loci are critical components of
hemoglobin. The globin loci are multi-gene clusters: in mice there are three functional α-
globins (ζ, α1 and α2) and four functional β-globins (εy, βH1, βmaj and βmin). Whereas primitive
erythroblasts express all of the globin genes, definitive erythrocytes express only the adult
globins (α1, α2, βmaj and βmin) (Trimborn et al., 1999). Therefore a transition occurs during
development (E10.5-E13.5) in which embryonic globin expression diminishes and adult globin
expression escalates.
Brg1 is recruited to the β-globin locus control region (LCR), a long-distance upstream
regulatory element, by erythroid-specific transcription factors, where it mediates chromatin
remodeling to allow transcription of β-globin genes in vitro (Kadam et al., 2000). We
hypothesized that the hemoglobin deficit observed in Brg1fl/fl:Tie2-Cre+/0 embryos could
result from inadequate globin transcription. Because of the mixed population of wild-type and
mutant blood cells in Brg1fl/fl:Tie2-Cre+/0 embryos at E9.5 (see Fig. 3D), we could not analyze
the expression of α-globin and β-globin genes by RT-PCR. Instead, we performed in situ
hybridization on sectioned embryos to visualize globin expression on a cell-by-cell basis.
Control embryos express all of the predominant globins expected to be detected at E9.5 in the
vast majority of their blood cells (Fig. 4A,C,E,G,I). Likewise, the adult α-globins (α1 and
α2) are expressed in almost every blood cell in mutant embryos at E9.5 (91.5±2.5%; Fig. 4D,I).
However, the embryonic globins ζ, εy and βH1 are only expressed in a subset of mutant blood
cells at E9.5 (63.75±8.6%, 57.25±7.8% and 42.9±6%, respectively; Fig. 4B,F,H,I).
Our laboratory previously showed that BRG1 is recruited to the β-globin LCR in definitive
erythrocytes in vivo, where it plays a crucial role in mediating adult β-globin transcription
(Bultman et al., 2005). To demonstrate that BRG1 is also recruited to the β-globin LCR in
primitive erythrocytes, we performed chromatin immunoprecipitation (ChIP) assays on
circulating blood cells collected from E9.5-E10.5 embryos. These cells are predominantly
primitive erythrocytes, as definitive erythrocytes first enter the bloodstream between E11.5-
E12.5 (Brotherton et al., 1979; Kingsley et al., 2004). Using an anti-BRG1 antibody, we were
able to demonstrate BRG1 binding to the DNAse I hypersensitive site 3 (HS3) of the β-globin
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LCR, where it is recruited in definitive erythrocytes as well (Fig. 4J). These ChIP data indicate
that the defects we detect in embryonic β-globin expression by in situ hybridization directly
result from loss of BRG1-induced chromatin remodeling at the β-globin LCR in mutant
primitive erythrocytes. Furthermore, we were able to detect BRG1 binding at the promoter of
the embryonic α-globin ζ, whereas BRG1 does not bind the promoter of the adult α-globins
α1/2 (Fig. 4J). These ChIP results for the α-globin genes are consistent with our in situ
hybridization results, which indicate BRG1 involvement in ζ but not α1/2 expression at E9.5.
Therefore, we provide the first evidence that BRG1 is important for embryonic α-globin
transcription in primitive erythrocytes. Overall, the reduction in blood cells expressing
embryonic globins, and the reduction in blood cells expressing Tie2-Cre by reporter analysis
in E9.5 mutant embryos (see Fig. 3D,E), lead us to hypothesize that primitive erythrocytes
having undergone excision of Brg1 are unable to support normal levels of embryonic globin
transcription, resulting in their destruction through apoptosis.
Vascular remodeling is abnormal in Brg1fl/fl:Tie2-Cre+/0 yolk sacs
Because Tie2-Cre is expressed in developing endothelium as well as in hematopoietic cells,
we analyzed the vasculature of Brg1fl/fl:Tie2-Cre+/0 embryos by immunostaining embryos and
yolk sacs with an antibody against the endothelial cell marker PECAM1. Yolk sac vascular
development consists of two major steps: vasculogenesis, the process by which new blood
vessels arise and form a primitive vascular plexus; and angiogenesis, the process by which the
homogenous plexus undergoes vascular remodeling resulting in a hierarchical vascular tree
comprising large and small vessels (Sato and Loughna, 2002). By E8.5, the time at which the
primitive vascular plexus is formed, Tie2-Cre-mediated excision occurs efficiently in yolk sac
endothelium (Fig. 3A,B). Yet Brg1fl/fl:Tie2-Cre+/0 yolk sac vasculature is indistinguishable
from that seen in control yolk sacs at this time (Fig. 5A,B), demonstrating that the vascular
plexus formation/maintenance stages of vasculogenesis proceed normally in mutant yolk sacs.
By E9.5, however, Brg1fl/fl:Tie2-Cre+/0 yolk sacs demonstrate an aborted vascular remodeling
process (Fig. 5D,E). Whereas their littermate controls successfully undergo angiogenesis,
resulting in yolk sacs with interconnected large and small vessels, mutant yolk sacs progress
beyond the plexus stage of vascular development but fail to establish a mature vascular tree.
Instead, the mutant yolk sac vasculature consists of small and medium-sized vessels that
occasionally fail to interconnect. Many dead-end or tapering vascular termini are visible in the
mutant yolk sacs, indicating that vascular sprouting or pruning fails to progress normally (Fig.
5E). Dysregulated cardiac function and blood flow are unlikely causes of these vascular
abnormalities because heart beat rates are normal and pericardial edema is rarely detected in
Brg1fl/fl:Tie2-Cre+/0 embryos at E9.5 when the yolk sac vascular abnormalities are readily
apparent. Interestingly, PECAM1 immunostaining of the vasculature within the mutant embryo
proper appears normal and comparable to that seen in control littermates or stage-matched
embryos at E9.5 (data not shown). Therefore, the vascular abnormalities we observe on the
Brg1fl/fl:Tie2-Cre+/0 background are specific to the yolk sac. Finally, although BRM
expression in the yolk sac is restricted to vascular endothelium (Dauvillier et al., 2001), we did
not see any exacerbation of the Brg1fl/fl:Tie2-Cre+/0 vascular phenotype on a Brm-/-
background. Therefore BRM does not appear to play a functionally redundant role with BRG1
during early vascular development.
DISCUSSION
BRG1 is one of two alternative catalytic subunits found in mammalian SWI/SNF-like
chromatin-remodeling complexes, which are important transcriptional regulators during
embryonic development. We provide the first evidence of a role for Brg1 in embryonic β-globin
expression and in primitive erythropoiesis in vivo. The phenotype of our conditional null
mutants is more severe than that of hypomorphic Brg1null/ENU1 embryos (Bultman et al.,
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2005). Erythroblasts in Brg1null/ENU1 embryos contain a stable BRG1 protein that assembles
into SWI/SNF-like complexes and retains normal ATPase activity. However, although the
mutant BRG1ENU1 protein is effectively recruited to the β-globin LCR, as demonstrated by
ChIP assays, the LCR does not establish DNAse I hypersensitive sites characteristic of open
chromatin. Because of this closed chromatin configuration at the LCR, adult β-globin
transcription is reduced in Brg1null/ENU1 embryos, and definitive erythroblasts undergo
developmental arrest, leading to embryonic lethality by E14.5. By contrast, Brg1fl/fl:Tie2-
Cre+/0 erythroblasts contain little or no BRG1 protein, and fail to transcribe embryonic β-
globins during primitive erythropoiesis, resulting in embryonic lethality by E11.0. Together,
these hypomorphic and conditional null mutations demonstrate the requirement for Brg1-
mediated chromatin remodeling during both embryonic and adult β-globin transcription.
Like Brg1fl/fl:Tie2-Cre+/0 mutants, mice targeted for deletion of the Krüppel-like factor 2
(Klf2) have a significant reduction of embryonic β-globin gene expression and an upregulation
of apoptosis in primitive erythrocytes (Basu et al., 2005). However, unlike Brg1fl/fl:Tie2-
Cre+/0 mutants, which die at E10.5-E11.0, Klf2-/- embryos persist until E12.5-E14.0, when
they succumb to heart failure (Lee et al., 2006). Notably, Klf2 is dispensable for adult β-globin
gene expression in definitive erythrocytes (Basu et al., 2005). Perhaps Brg1fl/fl:Tie2-Cre+/0
mutants die at E10.5 from anemia whereas Klf2-/- embryos do not become anemic, because
Brg1 is necessary for transcription of both embryonic and adult β-globins whereas Klf2 is only
critical for embryonic β-globin transcription. We hypothesize that embryonic β-globins are
required for the survival of primitive erythrocytes, but that definitive erythrocytes, which
express adult β-globins, can compensate for loss of primitive erythrocytes at the primitive/
definitive transition. This hypothesis is substantiated by the observation that mice depleted of
both of the embryonic β-globins survive development whereas embryos depleted of all of the
embryonic and adult β-globins, as a result of targeted deletion of the β-globin locus control
region, die early in embryogenesis (Bender et al., 2000; Hu et al., 2007).
In addition to deficits in embryonic β-globin transcription, we also observe a reduction in
embryonic α-globin (ζ) transcription in Brg1fl/fl:Tie2-Cre+/0 erythroblasts, although adult α-
globin transcription occurs normally in these cells (Fig. 4). Furthermore, we demonstrate
through ChIP assays that BRG1 binds the promoter of ζ but not the promoter of the adult α-
globins. These data indicate that BRG1 facilitates α-globin expression at the individual gene
promoters rather than at the major regulatory element (MRE), which is a long-distance
upstream regulatory element comparable to the β-globin LCR. In this regard, the regulation of
α-globin and β-globin expression by SWI/SNF-mediated chromatin remodeling appear to be
distinct in primitive erythrocytes. β-Thalassemia occurs when a reduced synthesis of β-globin
chains leads to an excessive accumulation of insoluble α-globin chains in red blood cells. The
resulting blood cells have morphological abnormalities (reminiscent of those seen in Fig. 1F
and Fig. 3D), and are vulnerable to mechanical injury and death. Although embryonic α-globin
expression is compromised in Brg1fl/fl:Tie2-Cre+/0 erythroblasts, the adult α-globins are
expressed normally and should be able to serve the survival needs of an embryo when β-globin
chains are available (Leder et al., 1997). However, because of defective β-globin transcription
in our mutant blood cells, the adult α-globins have no binding partners and presumably
accumulate detrimentally. Therefore, we provide the first demonstration that loss of Brg1 in
primitive erythroblasts leads to severe β-thalassemia and lethality.
Because SWI/SNF might be expected to mediate transcription of multiple genes during
erythropoiesis, we assessed expression of two other markers of erythroid development:
Alas2, an important enzyme in heme biosynthesis; and Band3 (Slc4a1), an integral membrane
protein on the surface of erythrocytes that provides cellular mechanical stability. By in situ
hybridization, we found normal expression of Alas2 but deficient expression of Band3 in
Brg1fl/fl:Tie2-Cre+/0 erythroblasts (see Fig. S2 in the supplementary material), indicating that
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BRG1-mediated chromatin remodeling may be important for Band3 transcription. Because
Band3-/- mice survive development (Peters et al., 1996;Southgate et al., 1996), we do not
believe that aberrant Band3 expression contributes to the lethality we observe in Brg1fl/fl:Tie2-
Cre+/0 embryos. Nevertheless, in combination with the globin expression data presented here,
these expression analyses provide interesting evidence for the specificity of SWI/SNF activity.
Altogether, we demonstrate changes in the expression of embryonic globins and Band3, but
no changes in the expression of adult α-globins or Alas2 in our mutant erythroblasts. These
data support a growing body of evidence that SWI/SNF complexes control a limited number
of targets and are not simply indiscriminate transcriptional regulators (reviewed by Kwon and
Wagner, 2007). As such, these and other chromatin remodeling complexes have the capacity
to regulate a wide variety of nuanced developmental processes.
Finally, we believe Brg1fl/fl:Tie2-Cre+/0 embryonic lethality is due to anemia resulting from
failure of hemoglobin synthesis and subsequent apoptosis of red blood cells, because other
mutants with defective primitive erythropoiesis, such as Gata1, Gata2 and Rbtn2 mutants, all
die from anemia at the same time in development as Brg1fl/fl:Tie2-Cre+/0 embryos (E10-E11.5)
(Fujiwara et al., 1996; Tsai et al., 1994; Warren et al., 1994). Importantly, these mutants with
defects in primitive erythropoiesis do not harbor secondary vascular defects. Therefore, we
suspect that the vascular phenotypes we observe in Brg1fl/fl:Tie2-Cre+/0 mutant yolk sacs are
separable from the mutant blood phenotype. We plan to verify this hypothesis in the future by
rescuing expression of Brg1 in developing erythrocytes and determining whether the vascular
abnormalities in Brg1fl/fl:Tie2-Cre+/0 yolk sacs are still apparent at E9.5.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Yolk sac-derived blood cells from Brg1fl/fl:Tie2-Cre+/0 embryos are scarce and
morphologically abnormal by E9.5
(A,B) Histological sections of Brg1fl/fl (A) and Brg1fl/fl:Tie2-Cre+/0 (B) yolk sac vessels filled
with hematopoietic blood cell progenitors, from littermate E8.5 embryos. (C,D) Histological
sections of a Brg1fl/fl yolk sac vessel (C) and a Brg1fl/fl:Tie2-Cre+/0 yolk sac vessel (D). The
mutant vessel is devoid of embryonic blood cells. Scale bars in A-D: 40 μm. (E,F) Transmission
electron micrographs of E10.5 Brg1fl/+ (E) and Brg1fl/fl:Tie2-Cre+/0 (F) yolk sac blood vessels.
Arrowheads indicate abnormal embryonic blood cells and blood cell fragments. EB, embryonic
blood cell; EC, endothelial cell; VE, visceral endoderm. Scale bars in E,F: 5 μm.
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Fig. 2. Yolk sac-derived blood cells from Brg1fl/fl:Tie2-Cre+/0 embryos undergo apoptosis at E9.5
(A-D) TUNEL staining on histological sections of E9.5 littermate control Brg1fl/fl (A) and
mutant Brg1fl/fl:Tie2-Cre+/0 (B) embryos, and their corresponding control (C) and mutant (D)
yolk sacs. The images were merged from separate DAPI (blue) and TUNEL (green)
acquisitions. The arrow in A points to the lumen of an embryonic heart (outlined in white),
filled with embryonic blood cells. The inset in B focuses on TUNEL-positive blood cells found
within one of the paired dorsal aortae (arrows and outlined in white) of the mutant embryo. No
TUNEL-positive blood cells are detected in the control yolk sac vessel (C; outlined in white),
but TUNEL-positive blood cells are evident in the mutant yolk sac vessel (D, outlined in white;
shown at higher magnification in the inset in D). Scale bars: 100 μm. (E) Mean percentages
of TUNEL-positive blood cells from multiple serial sections of two control and two mutant
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embryos stained in three independent experiments. A total of 596 and 362 blood cells were
counted from control and mutant sections, respectively. Errors were calculated as s.e.m.
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Fig. 3. Brg1fl/fl:Tie2-Cre+/0 blood cells are largely depleted by E9.5
Mutant embryos were crossed onto the ROSA26 reporter line and were stained with X-gal for
detection of β-galactosidase, which marks Cre-mediated excision events. (A,B) Blood vessels
from Brg1fl/+;R26RR/+:Tie2-Cre+/0 control (A) and Brg1fl/fl;R26RR/+:Tie2-Cre+/0 mutant (B)
E8.5 yolk sacs contain a comparable number of blood cell precursors, the majority of which
express Tie2-Cre. (C) The majority of circulating blood cell precursors still express Tie2-
Cre at E9.5 in Brg1fl/+;R26RR/+:Tie2-Cre+/0 control embryos. (D) By contrast, fewer
circulating blood cell precursors are found in Brg1fl/fl;R26RR/+:Tie2-Cre+/0 mutant embryos
at E9.5, but, of those cells that persist, the proportion of cells that express Tie2-Cre and are
presumably deficient for Brg1 expression is dramatically decreased when compared with the
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blood cells in the control embryo (C). The arrow in the inset points to an abnormally shaped
mutant (Brg1fl/fl:Tie2-Cre+/0) blood cell. Scale bar: 40 μm. (E) Mean percentages of Tie2-
Cre-positive (β-galactosidase-positive) blood cells from multiple serial sections of two control
and two mutant embryos at E8.5, and two control and two mutant embryos at E9.5, carrying
the ROSA26 reporter, as detected by X-gal staining. A total of 941 and 487 blood cells were
counted from control and mutant sections at E8.5, respectively, while a total of 1,656 and 893
blood cells were counted from control and mutant sections at E9.5, respectively. Errors were
calculated as s.e.m.
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Fig. 4. Brg1fl/fl:Tie2-Cre+/0 primitive erythroblasts have embryonic globin deficits
(A-H) Cryosections from an E9.5 control Brg1fl/fl embryo (A,C,E,G) and a mutant
Brg1fl/fl:Tie2-Cre+/0 embryo (B,D,F,H) were subjected to in situ hybridization with probes
against embryonic and adult α-globins and embryonic β-globins. Almost all embryonic blood
cells from the control embryo express embryonic α-globin ζ(A), adult α1/2-globins (C),
embryonic β-globin ϵy (E) and embryonic βH1-globin (G). In the mutant embryo, adult α1/2-
globin expression is normal (D), but many embryonic blood cells can be detected that express
little or no embryonic ζ (B), ϵy (F) or βH1 (H), as indicated by the arrowheads in the respective
insets. Scale bars: 40 μm. (I) Mean percentages of globin-expressing blood cells from multiple
serial sections of two control and two mutant embryos at E9.5, as detected by in situ
hybridization in three independent experiments. Total blood cells counted from control/mutant
sections with each probe were: ζ, 1521/907; α1/2, 1292/635; ϵy; 977/721; and βH1, 492/818.
Errors were calculated as s.e.m. (J) ChIP assay demonstrating that BRG1 is recruited to the
β-globin LCR DNAse I hypersensitive site 3 (HS3) and the ζ promoter in primitive
erythrocytes. No evidence of BRG1 recruitment is detected at the α1/2 promoter. MW, 100 bp
molecular weight standard; Pos, wild-type genomic DNA served as a positive control for the
PCR; Neg, no DNA was amplified as a negative control; Input, total chromatin, sheared but
not immunoprecipitated; Ac-H3, ChIP material immunoprecipitated with an antibody against
pan-acetyl histone 3 (H3), a mark of an open chromatin structure; BRG1, ChIP material
immunoprecipitated with an antibody against BRG1; Mock, mock immunoprecipitation in
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which the sample was not treated with antibody but was otherwise handled identically to the
ChIP samples.
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Fig. 5. Brg1fl/fl:Tie2-Cre+/0 yolk sac vascular remodeling is abnormal
(A,B) Anti-PECAM1-stained yolk sacs from E8.5 littermate Brg1fl/+ (A) and Brg1fl/fl:Tie2-
Cre+/0 (B) embryos display a comparable vascular plexus. (C,D) Anti-PECAM1-stained yolk
sacs from E9.5 littermate Brg1fl/fl (C) and Brg1fl/fl:Tie2-Cre+/0 (D) embryos. (E) A higher
magnification view of a different region of the Brg1fl/fl:Tie2-Cre+/0 yolk sac shown in D.
Arrows indicate sprouting or regressing vessels; arrowheads indicate abnormally thin vessels.
Scale bars: 500 μm.
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Table 1
Brg1fl/fl:Tie2-Cre+/0 embryos die during development





Brg1fl/fl females were mated with Brg1fl/+:Tie2-Cre+/0 males, and live progeny from 24 litters were genotyped and scored at weaning. No live
Brg1fl/fl:Tie2-Cre+/0 mice were recovered [χ2(3dof): P<0.001].
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Table 2
Brm-/-;Brg1fl/+:Tie2-Cre+/0 embryos do not die during development





Brm-/-;Brg1fl/fl females were mated with Brm-/-;Brg1fl/+:Tie2-Cre+/0 males, and live progeny from 12 litters were genotyped and scored at weaning.
Only one live Brm-/-;Brg1fl/fl:Tie2-Cre+/0 mouse was recovered [χ2(3dof): P<0.001].
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